Equity [Text Block] | 5. CAPITAL STOCK AND ADDITIONAL PAID IN CAPITAL The holders of common stock are entitled to one not no Common Stock Issuances During the nine months ended September 30, 2024, and the year ended December 31, 2023, there were no share issuances pursuant to private placements. Warrants A summary of warrant activity for the nine-month period ended September 30, 2024, are as follows: Number of warrants Exercise price Expiry date Outstanding December 31, 2023 37,803,218 CAD$ 0.1075 May 20 - June 14, 2027 Outstanding September 30, 2024 37,803,218 CAD$ 0.1075 May 20 - June 14, 2027 A fair value of the derivative liability of $1,781,779 was estimated on the date of the subscription using the Black-Scholes pricing model. A fair value of the derivative liability of $283,373 was estimated at December 31, 2023, using the Black-Scholes pricing mode. For the nine-month period ended September 30, 2024, there was a non-cash gain on derivative liability – warrants of $70,062 (September 30, 2023 - $714,209) and an unrealized foreign exchange gain of $3,877 (September 30, 2023 - $2,832) resulting in a fair value as at September 30, 2024 of $199,991 with the following weighted average assumptions: September 30, 2024 Issuance date Exercise price CAD$ 0.1075 CAD$ 0.1075 Stock price CAD$ 0.015 CAD$ 0.09 Expected term (in years) 2.68 5 Expected dividend yield - - Expected stock price volatility 146.19 % 85.69 % Risk-free interest rate 3.04 % 2.73 % Stock Options The Company established a stock option plan (the “Plan”) under which it is authorized to grant options to executive officers and directors, employees and consultants and the number of options granted under the Plan shall not exceed 10% of the shares outstanding. Under the Plan, the exercise period of the options may not exceed ten Stock option transactions are summarized as follows: Stock Options Number Weighted average exercise price in Canadian $ Outstanding, December 31, 2022 34,665,000 $ 0.14 Granted 11,400,000 0.035 Expired (6,050,000 ) 0.22 Outstanding, December 31, 2023 40,015,000 0.10 Expired (3,290,000 ) 0.15 Outstanding, September 30, 2024 36,725,000 $ 0.09 Number currently exercisable 36,725,000 $ 0.09 As at September 30, 2024, incentive stock options were outstanding as follows: Number of Options Outstanding Number of Options Exercisable Exercise Price in Canadian $ Expiry Date Options 7,450,000 7,450,000 0.065 March 19, 2025 100,000 100,000 0.075 May 22, 2025 5,900,000 5,900,000 0.140 November 13, 2025 6,175,000 6,175,000 0.180 May 23, 2026 5,700,000 5,700,000 0.085 June 24, 2027 11,400,000 11,400,000 0.035 November 14, 2028 36,725,000 36,725,000 As at September 30, 2024 the Company’s outstanding and exercisable stock options have an aggregate intrinsic value of $ Nil Nil Stock-based compensation During the 9-month period ended September 30, 2024, the Company recognized as part of salaries and benefits, stock-based compensation of $ Nil nil nil |